🇺🇸 botulinum type a in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 5

Most-reported reactions

1. Arthralgia — 1 report (20%)
2. Burning Sensation — 1 report (20%)
3. Hypoaesthesia — 1 report (20%)
4. Neuropathic Pain — 1 report (20%)
5. Pain In Extremity — 1 report (20%)

Source database →

Frequently asked questions

Is botulinum type a approved in United States?

botulinum type a does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for botulinum type a in United States?

Henry Ford Health System is the originator. The local marketing authorisation holder may differ — check the official source linked above.